國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Hepatitis C in developing countries ...

Kamal, Sanaa M.,

Hepatitis C in developing countries :current and future challenges /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Hepatitis C in developing countries :edited by Sanaa M. Kamal.
其他題名:	current and future challenges /
其他作者:	Kamal, Sanaa M.,
面頁冊數:	1 online resource
標題:	Hepatitis CDeveloping countries.
電子資源:	https://www.sciencedirect.com/science/book/9780128032336
ISBN:	9780128032343$q(electronic bk.)

Hepatitis C in developing countries :current and future challenges /
Hepatitis C in developing countries :current and future challenges /edited by Sanaa M. Kamal. - 1 online resource

Includes bibliographical references and index.

Hepatitis C virus / Ahmed Abdel Aziz -- Epidemiology and modes of transmission of HCV in developing countries / Sanaa M. Kamal and Dahlia Ghoraba -- Public health and economic burden of Hepatitis C infection in developing countries / Tamer A. Hafez -- Social, cultural, and political factors influencing HCV in developing countries / Sara A. Abdelhakam and Mohamad A. Othman -- Hepatitis C in Egypt / Sanaa M. Kamal and Sara A. Abdelhakam -- Hepatitis C in North Africa (Arabic Maghreb region) / Mohamed A. Daw -- Hepatitis C virus in sub-saharan Africa / Osi Obadahn and Sanaa M. Kamal -- Hepatitis C virus infection in the Indian sub-continent / Shashi Shekhar -- Hepatitis C in developing countries in southeast Asia / Thi Q. Doan -- Hepatitis C and schistosomisasis coinfection / Sanaa M. Kamal -- Hepatitis C and Helminthic infections / Khalifa S. Khalifa and Othman Amin -- Hepatitis C and HIV coinfection in developing countries / Ozlem Tastan Bishop -- Hepatiis B and C coinfection / Georgios Zacharakis -- Hepatitis C infection in patients with hemogloinopathies / Sanaa M.Kamal and Ahmed M. Fouad -- Hepatitis C in patients on hemodialysis / Tamer A. Hafez -- Hepatitis C screening and diagnosis in developing countries / Huda H. Gaafar -- Hepatitis C treatment in the era of direct-acting antiviral agents / Sanaa M. Kamal.

"Hepatitis C in Developing Countries: Current and Future Challenges explores the current state of HCV in several countries, including Africa, Asia and South America. It maintains a dedicated focus on the epidemiology, clinical patterns, virologic diversity, coinfections, natural history and progression, complications, and response to standard of care (SOC) pegylated interferon and ribavirin therapy of HCV with recommendations specific to middle and low income countries. Readers will find detailed information on the burden of HCV infection from a global health and economic perspective, along with data from multicenter trials on DAAs that have enrolled patients infected with HCV non-genotype 1.Features coverage on the prevention of, or inhibition of, liver fibrosis, cirrhosis, and hepatocellular carcinomaPresents data from trials on patients with diverse ethnic backgrounds and those infected with genotypes 3, 4, 5, 6Addresses the epidemiology, modes of transmission, socio-political aspects, genotypes, and co-infections of Hepatitis C"--

ISBN: 9780128032343$q(electronic bk.)Subjects--Topical Terms:

846239
Hepatitis C
--Developing countries.Index Terms--Genre/Form:

214472
Electronic books.

LC Class. No.: RC848.H425

Dewey Class. No.: 616.3623/00917/4

Hepatitis C in developing countries :current and future challenges /
LDR:03522cmm a2200301 i 4500 001 561728
006 m o d
007 cr cnu|||unuuu
008 200213s2018 enk ob 001 0 eng d
020 $a 9780128032343$q(electronic bk.)
020 $a 0128032340$q(electronic bk.)
020 $a 9780128032336
035 $a (OCoLC)1013462524 $z (OCoLC)1013521004 $z (OCoLC)1031874584
035 $a els69900465
040 $a N $b eng $e rda $e pn $c N $d N $d OPELS $d UAB $d IDEBK $d OCLCF $d MERER $d YDX $d UPM $d OCLCQ $d D6H $d DKU $d CASUM $d OCLCO
041 0 $a eng
043 $a d------
050 4 $a RC848.H425
082 0 4 $a 616.3623/00917/4 $2 23
245 0 0 $a Hepatitis C in developing countries : $b current and future challenges / $c edited by Sanaa M. Kamal.
264 1 $a London, United Kingdom : $b Academic Press is an imprint of Elsevier, $c [2018]
300 $a 1 online resource
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
504 $a Includes bibliographical references and index.
505 0 $a Hepatitis C virus / Ahmed Abdel Aziz -- Epidemiology and modes of transmission of HCV in developing countries / Sanaa M. Kamal and Dahlia Ghoraba -- Public health and economic burden of Hepatitis C infection in developing countries / Tamer A. Hafez -- Social, cultural, and political factors influencing HCV in developing countries / Sara A. Abdelhakam and Mohamad A. Othman -- Hepatitis C in Egypt / Sanaa M. Kamal and Sara A. Abdelhakam -- Hepatitis C in North Africa (Arabic Maghreb region) / Mohamed A. Daw -- Hepatitis C virus in sub-saharan Africa / Osi Obadahn and Sanaa M. Kamal -- Hepatitis C virus infection in the Indian sub-continent / Shashi Shekhar -- Hepatitis C in developing countries in southeast Asia / Thi Q. Doan -- Hepatitis C and schistosomisasis coinfection / Sanaa M. Kamal -- Hepatitis C and Helminthic infections / Khalifa S. Khalifa and Othman Amin -- Hepatitis C and HIV coinfection in developing countries / Ozlem Tastan Bishop -- Hepatiis B and C coinfection / Georgios Zacharakis -- Hepatitis C infection in patients with hemogloinopathies / Sanaa M.Kamal and Ahmed M. Fouad -- Hepatitis C in patients on hemodialysis / Tamer A. Hafez -- Hepatitis C screening and diagnosis in developing countries / Huda H. Gaafar -- Hepatitis C treatment in the era of direct-acting antiviral agents / Sanaa M. Kamal.
520 $a "Hepatitis C in Developing Countries: Current and Future Challenges explores the current state of HCV in several countries, including Africa, Asia and South America. It maintains a dedicated focus on the epidemiology, clinical patterns, virologic diversity, coinfections, natural history and progression, complications, and response to standard of care (SOC) pegylated interferon and ribavirin therapy of HCV with recommendations specific to middle and low income countries. Readers will find detailed information on the burden of HCV infection from a global health and economic perspective, along with data from multicenter trials on DAAs that have enrolled patients infected with HCV non-genotype 1.Features coverage on the prevention of, or inhibition of, liver fibrosis, cirrhosis, and hepatocellular carcinomaPresents data from trials on patients with diverse ethnic backgrounds and those infected with genotypes 3, 4, 5, 6Addresses the epidemiology, modes of transmission, socio-political aspects, genotypes, and co-infections of Hepatitis C"-- $c Provided by publisher.
650 0 $a Hepatitis C $z Developing countries. $3 846239
650 1 2 $a Hepatitis C. $3 502163
650 2 2 $a Developing Countries. $3 295315
650 2 2 $a Hepacivirus. $3 846240
655 4 $a Electronic books. $2 local. $3 214472
700 1 $a Kamal, Sanaa M., $e editor. $3 846238
856 4 0 $u https://www.sciencedirect.com/science/book/9780128032336